by Nicola Blackburn | Jul 14, 2025
A significant development has emerged from the ACCENT pancreatic cancer clinical trial sponsored by Amplia Therapeutics in collaboration with Professor Paul Timpson at the Garvan Institute of Medical Research, two patients have achieved a pathological complete...
by Nicola Blackburn | Mar 24, 2025
Researchers at the Garvan institute have published findings revealing a promising new therapeutic target to slow down or inhibit metastasis in pancreatic cancer. The study identified a metabolic signaling molecule involved in facilitating the spread of the disease to...
by Nicola Blackburn | Jul 5, 2024
Prof Paul Timpson, head of the Invasion and Metastasis Lab, Professor Thomas Cox and Dr Brooke Pereira of the Garvan Institute of Medical Research were awarded funding from the Cancer Council to continue research into advancing treatment options for pancreatic cancer....
by Nicola Blackburn | Nov 16, 2023
Professor Anthony Gill was honoured as the winner of the 2023 Outstanding Cancer Researcher of the Year for his significant contributions to the field of cancer diagnosis and pathology. The Premier’s Awards for Outstanding Cancer Research is the highest accolade for...
by Nicola Blackburn | Nov 16, 2023
November is recognised as World Pancreatic Cancer Awareness Month where we take time to raise awareness of the disease. The theme for this year is ‘Hello Pancreas’, an engaging way of helping people to become more aware of the pancreas organ, it’s...
